LONG TERM FOLLOW UP OF OUTCOMES WITH F-18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IMAGING- ASSISTED MANAGEMENT OF PATIENTS WITH SEVERE LEFT VENTRICULAR DYSFUNCTION SECONDARY TO CORONARY DISEASE: 5-YEAR FOLLOW-UP OF THE PARR-2 RANDOMIZED CONTROLLED TRIALTushar Shukla, R.S. Beanlands, Brian A. Mc Ardle et al.|Canadian Journal of Cardiology|2014Cited by 3
190 Immunohistochemical Validation of [18f]-Fluorodeoxyglucose as a Novel Biomarker of Inflamed Vulnerable Carotid Plaque: A Sub-Study of the Canadian Atherosclerosis Imaging Network (CAIN)Myra Cocker, R.S. Beanlands, J. Keirn Brennan et al.|Canadian Journal of Cardiology|2012Cited by 1
595 Evaluation of [18F]PyKYNE-losartan in rats using pet imagingNatasha Arksey, Jean N. DaSilva, Stephanie Thorn et al.|Canadian Journal of Cardiology|2011Cited by 0
Evidence for Actively Inflamed Bilateral Carotid Plaque in Patients With Advanced Atherosclerosis, Insight From [18F]-Fluorodeoxyglucose Imaging: A Sub-Study of the Canadian Atherosclerosis Imaging Network (CAIN)MS Cocker, R.S. Beanlands, Jason R. Spence et al.|Canadian Journal of Cardiology|2013Cited by 0
487 The use of 18F-FDG to detect changes in atherosclerotic lesions in atherogenic apoE −/− miceLyne Sleiman, R.S. Beanlands, T. Stephanie et al.|Canadian Journal of Cardiology|2011Cited by 0